Global Trust Asset Management LLC Increases Holdings in Solventum Co. (NYSE:SOLV)

Global Trust Asset Management LLC lifted its position in Solventum Co. (NYSE:SOLV) by 137.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 570 shares of the company’s stock after purchasing an additional 330 shares during the period. Global Trust Asset Management LLC’s holdings in Solventum were worth $38,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Modus Advisors LLC bought a new stake in shares of Solventum during the 4th quarter valued at about $25,000. Copeland Capital Management LLC purchased a new position in shares of Solventum in the third quarter worth approximately $26,000. Mather Group LLC. bought a new stake in Solventum during the third quarter valued at approximately $27,000. Twin Lakes Capital Management LLC purchased a new stake in Solventum during the second quarter valued at approximately $29,000. Finally, Kayne Anderson Rudnick Investment Management LLC bought a new position in Solventum in the second quarter worth approximately $32,000.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Morgan Stanley upped their price objective on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. Wolfe Research assumed coverage on Solventum in a research report on Thursday, September 26th. They issued a “peer perform” rating for the company. Piper Sandler lifted their price objective on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. Stifel Nicolaus assumed coverage on shares of Solventum in a report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 target price for the company. Finally, Mizuho started coverage on shares of Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $68.29.

Solventum Price Performance

Shares of SOLV opened at $73.68 on Thursday. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $96.05. The company has a 50 day simple moving average of $69.22 and a two-hundred day simple moving average of $66.02. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45.

Solventum (NYSE:SOLV) last announced its quarterly earnings results on Thursday, November 7th. The company reported $1.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.38 by ($0.23). The business had revenue of $2.08 billion for the quarter, compared to the consensus estimate of $2.05 billion. Sell-side analysts anticipate that Solventum Co. will post 6.58 earnings per share for the current year.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.